OpenVSafe by OpenVAERS
Search V-safe

XUJ-28359-88691

4 vaccinations 4 coded responses 37 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
191 / PA
Registered
2020-12-29
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2020-12-28
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-29
    Registered in v-safe
  3. 2020-12-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-04
    Health check-in — 7 day, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-11
    Health check-in — 14 day, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-01-19
    Dose 2 — Pfizer-BioNTech
  11. 2021-01-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  12. 2021-01-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chills, Fatigue, Impaired work ability, Myalgia, Self-medication — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  13. 2021-01-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-01-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-01-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-26
    Health check-in — 7 day, dose 2
    Feeling: Good · Headache
    Adult check-in
  17. 2021-02-02
    Health check-in — 14 day, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-02-09
    Health check-in — 21 day, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-02-16
    Health check-in — 28 day, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-23
    Health check-in — 35 day, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-02
    Health check-in — 42 day, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-20
    Health check-in — 3 month, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-07-20
    Health check-in — 6 month, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-10-05
    Dose 3 — Pfizer-BioNTech
  25. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Muscle or body aches
    Adult check-in
  26. 2021-10-08
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good
    MedDRA releases: 2024-11 · check-in answers available
  27. 2021-10-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  28. 2021-10-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  29. 2021-10-12
    Survey response — 7 day, dose 3
    MedDRA: Nasal congestion — Feeling: Fair · Headache
    MedDRA releases: 2024-11 · check-in answers available
  30. 2021-10-19
    Health check-in — 14 day, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-10-26
    Health check-in — 21 day, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-11-02
    Health check-in — 28 day, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-11-09
    Health check-in — 35 day, dose 3
    Feeling: Good
    Adult check-in
  34. 2021-11-16
    Health check-in — 42 day, dose 3
    Feeling: Good
    Adult check-in
  35. 2022-01-04
    Health check-in — 3 month, dose 3
    Feeling: Good
    Adult check-in
  36. 2022-04-07
    Survey response — 6 month, dose 3
    MedDRA: Anosmia, COVID-19, Diarrhoea, Dyspnoea, Fatigue, Nausea, Pain — Feeling: Good · Be unable to work or attend school
    MedDRA releases: 2024-11 · check-in answers available
  37. 2022-09-02
    Dose 4 — Moderna
  38. 2022-10-08
    Health check-in — 35 day, dose 4
    Feeling: Good
    Adult check-in
  39. 2022-10-08
    Health check-in — 12 month, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-10-15
    Health check-in — 42 day, dose 4
    Feeling: Good
    Adult check-in
  41. 2022-12-02
    Health check-in — 3 month, dose 4
    Feeling: Good
    Adult check-in
  42. 2023-03-05
    Health check-in — 6 month, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-28Pfizer-BioNTech
22021-01-19Pfizer-BioNTech
32021-10-05Pfizer-BioNTech No
42022-09-02Moderna No

Free text

Release 2

Systemic reaction (other): I had chills, mildly elevated temperature (99.6F), muscle/body aches, and fatigue up to 48h after receiving the vaccine but before I received this follow up survey to report current symptoms. They did make me feel too ill to work but resolved after 48h and I managed them with Tylenol.

Release 10

Systemic reaction (other): ongoing swollen, tender axillary lymph node under arm of injection site

Systemic reaction (other): nasal congestion

Release 11

Symptoms: symptoms due to COVID-19 infection: fatigue, shortness of breath, body aches, nausea, diarrhea, loss of smell

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnosmia · · ✓
SDCOVID-19 · · ✓
SDDiarrhoea · · ✓
SDDyspnoea · · ✓
SDFatigue · · ✓
SDNausea · · ✓
SDPain · · ✓
SROChills ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROImpaired work ability ✓ ✓ ✓
SROLymph node pain · · ✓
SROLymphadenopathy · · ✓
SROMyalgia ✓ ✓ ✓
SRONasal congestion · · ✓
SROSelf-medication ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release